论文部分内容阅读
目的探讨沐舒坦佐治新生儿肺炎的疗效。方法将83例新生儿肺炎随机分为治疗组43例,对照组40例,治疗组另加沐舒坦5～10mg/d静脉滴注,观察疗效。结果治疗组患儿喘憋、咳嗽、紫绀等临床症状改善以及氧疗时间与住院天数均较对照组短。结论沐舒坦能有效改善患者临床症状,减少氧疗时间,缩短住院天数,与抗生素合用有协同作用,是治疗新生儿肺炎有效辅助药物。
Objective To investigate the curative effect of mucosolvan in the treatment of neonatal pneumonia. Methods 83 cases of neonatal pneumonia were randomly divided into treatment group 43 cases, control group 40 cases, the treatment group plus mucosolvan 5 ~ 10mg / d intravenous infusion to observe the effect. Results The improvement of clinical symptoms such as wheezing, cough, cyanosis, and the days of oxygen therapy and hospital stay in the treatment group were shorter than those in the control group. Conclusion Mucosolvan can effectively improve the clinical symptoms, reduce the oxygen therapy time and shorten the length of hospital stay, and synergistic effect with antibiotics, is an effective adjuvant drug for the treatment of neonatal pneumonia.